Search clinical trials for: Pioglitazone placebo

Total 54177 results

Merck Sharp & Dohme LLC

Completed

MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)

Type 2 Diabetes Mellitus
Yonsei University

Unknown

Comparison of The Effects of Thiazolidinediones(TZD), Sodium- Glucose Cotransporter 2 Inhibitors(SGLT2i) Alone and TZD / SGLT2i Combination Therapy on Non-alcoholic Fatty Liver Disease in Type 2 Diabetic Patients With Fatty Liver

Type2 Diabetes | NAFLD - Nonalcoholic Fatty Liver Disease

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

Diabetes Mellitus Type 2

France, United States, Mexico, United Kingdom, Spain, Canada, New Zealand, Thailand, Russian Federation, Brazil, Germany, Australia, Poland, Slovakia, Peru, Ukraine, South Africa, Costa Rica, Puerto Rico
University of Texas Southwestern Medical Center

Terminated

Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine

Pancreatic Cancer

United States
Taipei Veterans General Hospital, Taiwan

Unknown

Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy

Diabetes

Taiwan
Mario Negri Institute for Pharmacological Research
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Humanitas Hospital,...

Recruiting

Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. (TRABEPIO)

Liposarcoma, Myxoid | Liposarcoma, Dedifferentiated | Liposarcoma, Round Cell

Italy
Samaritan Health Services

Completed

GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study (GOTCHA)

Coronavirus Infection | Diabetes

United States
Onofre, Aurora Pujol, M.D.
Instituto de Salud Carlos III; Fundacion Hesperia; ELA España Association

Completed

Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy (XAMNPIOP2011)

Adrenomyeloneuropathy | X-linked Adrenoleukodystrophy

Spain
Imperial College London

Completed

Pioglitazone on Cardiac Function and Large Arteries (PICCOLA Study) (PICCOLA)

Diabetes

United Kingdom
National Cheng-Kung University Hospital

Unknown

Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes

Type 2 Diabetes

Taiwan
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Type 2 Diabetes Mellitus With Complication

China
University of Maryland, Baltimore
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Pharmacogenomics of Thiazolidinediones (PPAR)

Type 2 Diabetes

United States
Johns Hopkins University

Completed

Study of Pioglitazone in Sporadic Inclusion Body Myositis

Nervous System Diseases | Muscular Diseases | Neuromuscular Diseases | Myositis | Musculoskeletal Disease | Inclusion Body Myositis

United States
University Hospitals Cleveland Medical Center
National Alliance for Research on Schizophrenia and Depression; Takeda Pharmaceuticals...

Completed

Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

Metabolic Syndrome | Insulin Resistance | Bipolar Depression

United States
AstraZeneca

Completed

Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Pioglitazone to Treat Fatty Liver in People With HIV Infection

HIV Infections | Insulin Resistance | Hepatic Steatosis

United States
National Institute of Diabetes and Digestive and...

Completed

Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

Fatty Liver | Nonalcoholic Steatohepatitis

United States
Takeda

Completed

Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.

Diabetes Mellitus

Netherlands, Sweden
Takeda

Completed

Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. (SPLENDOR)

Diabetes Mellitus

Italy
Rambam Health Care Campus

Recruiting

A Pilot Study of Monitoring Insulin Levels and Treating Hyperinsulinemia and Hyperglycemia With Pioglitazone in Patients Treated With Alpelisib for Metastatic Breast Cancer.

Hyperinsulinism | Metastatic Breast Cancer | Hyperglycemia Drug Induced

Israel
Takeda

Completed

Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

Diabetes Mellitus, Type 2, Cancer
Korea University Anam Hospital

Completed

The Effect of Pioglitazone on Neointima Volume and Characteristics Observed by Optical Coherence Tomography (OCT)

Diabetic Stable Angina | Diabetic Unstable Angina

Korea, Republic of
M.V. Hospital for Diabetes
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals

Completed

Role of Pioglitazone in Preventing Diabetes

Diabetes
University of Aarhus

Completed

The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients

Growth Hormone Deficiency

Denmark
Merck Sharp & Dohme LLC

Completed

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Type 2 Diabetes Mellitus With Complication
Getz Pharma

Recruiting

Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

Diabetes Mellitus, Type 2 | NAFLD | NASH - Nonalcoholic Steatohepatitis

Pakistan
Cairo University

Active, not recruiting

Efficacy and Safety of Dapagliflozin in Patients With Non-alcoholic Steatohepatitis

Non-alcoholic Steatohepatitis

Egypt
Tanta University

Not yet recruiting

Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis

Non Alcoholic Steatohepatitis

Egypt
Chang Gung Memorial Hospital
National Taiwan University Hospital; Chiayi Christian Hospital; Tainan Sin-lau...

Recruiting

Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke

Stroke | Diabetes Mellitus

Taiwan
Emory University

Terminated

Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia

Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
Henry Ford Health System

Completed

Topical Capsaicin for Cyclical Vomiting

Cyclical Vomiting

United States
Jinnah Postgraduate Medical Centre

Not yet recruiting

Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD

Non-Alcoholic Fatty Liver Disease | Type2diabetes

Pakistan
Merck Sharp & Dohme LLC

Completed

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)

Diabetes Mellitus, Type 2
Children's Hospital of Fudan University

Terminated

Pioglitazone Therapy for Chronic Granulomatous Disease

Chronic Granulomatous Disease

China
Takeda

Completed

Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"

Type 2 Diabetes Mellitus
University of Michigan
National Cancer Institute (NCI)

Completed

Pioglitazone in Thyroid Cancers

Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene

United States
Philip Kern
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Mechanisms Underlying Metabolic Syndrome in Obesity

Metabolic Syndrome | Insulin Resistance | Prediabetes

United States
Takeda

Completed

Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"

Type 2 Diabetes Mellitus
Pennington Biomedical Research Center
Takeda Pharmaceuticals North America, Inc.

Completed

"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM

Diabetes Mellitus, Type 2

United States
National Institute on Aging (NIA)

Terminated

Androgen Deprivation Therapy Study (ADT)

Inflammation | Diabetes | Metabolic Syndrome | Hypogonadism

United States
Bristol-Myers Squibb
Merck Sharp & Dohme LLC

Completed

Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
NGM Biopharmaceuticals, Inc

Completed

Study of NGM313 in Obese Participants

Obese

United States
Takeda

Completed

Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>

Type 2 Diabetes Mellitus
University of Campania "Luigi Vanvitelli"

Completed

Pioglitazone Versus Metformin in Type 2 Diabetes

Type 2 Diabetes

Italy
University of Rochester

Completed

Preventing Squamous Cell Skin Cancer

Squamous Cell Carcinoma of the Skin
Children's Hospital Medical Center, Cincinnati

Completed

Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis (PioPAP)

Autoimmune Pulmonary Alveolar Proteinosis

United States
Takeda

Completed

Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"

Type 2 Diabetes Mellitus
Takeda
Kaiser Permanente; Department of Epidemiology at University of Pennsylvania

Completed

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

Diabetes | Bladder Cancer
GlaxoSmithKline

Completed

Study In People With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Argentina, Canada, Peru, Australia, Latvia, Costa Rica, Russian Federation, New Zealand, Colombia, Mexico, Czech Republic, Ecuador

Search clinical trials for: Pioglitazone placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations